The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20070509
Martin et al.

Figure S1 Normal CHS response to TNCB in TLR4-deficient BALB/c lps/lps mice.

Figure S2 IFN-γ production by lymph node cells of mice sensitized with oxazolone or FITC.

Figure S3 Histopathological changes in CHS skin lesions induced by a repeated exposure to FITC

Figure S4 TNCB-induced CHS in C57BL/10 mice is mediated by Tc1 cells.

Figure S5 Restoration of the sensitizing capacity for CHS of TLR4/IL-12Rβ2−/− DC-TNP by pretreatment with CpG-ODN but not with control ODN (CpG-GC).

Figure S6 TNBS fails to induce cytokine production in DC from IL-12Rβ2−/− mice.

Figure S7 Only WT DC-TNP induce CHS in germ-free IL-12Rβ2−/− mice.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS